Often characterized by involuntary motor or vocal tics, Tourette syndrome typically appears in childhood and affects up to 450,000 Americans. While symptoms fade for some patients ...
If Emalex’s drug makes it to market, it will be the first new type of treatment for Tourette syndrome to win approval in 56 years, the company’s chief medical officer recently said.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results